SCHEMBL7859810

SCHEMBL7859810

CN1CCC(c2cc3cc(F)c(F)cc3[nH]2)CC1

nearest known ligand 0.48

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 1/20 0.42
TLR9 Q9NR96 1/20 0.41
TLR8 Q9NR97 1/20 0.41
TLR7 Q9NYK1 1/20 0.41
APP P05067 1/20 0.39
CCNT1 O60563 4/20 0.38
CDK9 P50750 4/20 0.38
CASP3 P42574 1/20 0.37
CASP7 P55210 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL7870782 0.81 HRH4 (0.50) MAPK14CCNT1CDK9CASP3CASP7
Bromide SCHEMBL7859742 0.81 MAPK14 (0.48) MAPK14CCNT1CDK9CASP3CASP7
SCHEMBL15219331 0.77 HRH4 (0.55) CCNT1CDK9
SCHEMBL7203954 0.76 HRH4 (0.53)
Bromide SCHEMBL8820626 0.74 CDK9 (0.45) CCNT1CDK9CASP3CASP7
Bromide SCHEMBL7865092 0.74 HRH4 (0.51) MAPK14CCNT1CDK9
SCHEMBL11916126 0.74 HRH4 (0.41) MAPK14
SCHEMBL7503773 0.72 HRH4 (0.52) MAPK14CCNT1CDK9
SCHEMBL26684171 0.69 YTHDF2 (0.43) MAPK14
SCHEMBL7867370 0.68 APP (0.65) APP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1077213-A2 Inhibition of serotonin reuptake ELI LILLY AND COMPANY (US) 2001-02-21 EP disclosed
US-6046215-A A PIPERIDINYLBENZOTHIOPHENES USEFUL FOR TRATING BRAIN DISORDERS ELI LILLY AND COMPANY (US) 2000-04-04 US disclosed
US-5846982-A Inhibition of serotonin reuptake ELI LILLY AND COMPANY (US) 1998-12-08 US disclosed
EP-0812826-A1 1H-indole and benzo(b)thiophene derivatives with 4-(1,2,3,6-tetra:hydro:pyridinyl)- and 4-piperidinyl-groups bound to the heterocyclic ring as inhibitors of serotonin reuptake ELI LILLY AND COMPANY (US) 1997-12-17 EP disclosed